Epigenetic silencing of Id4 in leukemia [19], breast [20,21], colorectal [22] mouse and human CLL (chronic lymphocytic leukemia [23]) and gastric cancer [24] tend to support its anti-tumor activity. Here, ID4 is linked to neoplasm.